Kolesnyk M O, Lapchyns'ka I I, Pryshchepa P P
Lik Sprava. 1995 Mar-Apr(3-4):162-4.
The immediate positive result of 3-4 weeks' course of treatment with curantyl (C) of patients with chronic glomerulonephritis (ChGN) is due to both vasoactive and antiaggregant action of the preparation. The negative immediate result of C treatment appear to be associated with <
用库兰特(C)对慢性肾小球肾炎(ChGN)患者进行3至4周疗程治疗的即时积极效果,归因于该制剂的血管活性和抗聚集作用。C治疗的即时负面效果似乎与“窃血综合征”有关。已发现C对肾内以纤维增生性改变为主的ChGN患者、患有动脉高血压的ChGN患者(I级)的治疗有效。在停用C 1.5至2年后对治疗的远期效果进行分析发现,与对照组相比,22.5%的患者健康状况有所改善,15%的患者ChGN进展减缓。